How to achieve EMA policy 0070 compliance

How to achieve EMA policy 0070 compliance

Following on from our recent webinar on Achieving EMA policy 0070 compliance (click here to view the full recording), we’ve created a step-by-step guide to help organisations create a process to efficiently complete any data anonymisation project. 

Download PDF

Under EMA Policy 0070, your organisation must prepare anonymised versions of  clinical reports so that subjects cannot be re-identified, while retaining the data’s value for independent secondary analyses. This is not just a requirement for European organisations. In the US, the FDA is taking similar steps now too, with the launch of a new pilot initiative around clinical study reports.

Read the infographic below and learn how your organisation can use our best practices to develop a systematic solution.
Infographic - A best practice approach for achieving EMA policy 0070 compliance
Download PDF

We’re currently offering a free consultation with a Kinapse expert for any organisation looking to improve the way they approach clinical data anonymisation projects. To book your 1 to 1 assessment, follow the link below:

Talk to a Kinapse expert

Book your 1 to 1 assessment

Share this page:
2018-04-16T13:54:04+00:00